GSK.LGSK.L
LOADING
|||
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-14.48%
↓ 546% below average
Average (39q)
3.25%
Historical baseline
Range
High:41.37%
Low:-30.26%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -14.48% |
| Q2 2025 | 41.37% |
| Q1 2025 | -23.91% |
| Q4 2024 | 27.41% |
| Q3 2024 | 0.91% |
| Q2 2024 | 4.01% |
| Q1 2024 | 6.77% |
| Q4 2023 | -9.94% |
| Q3 2023 | 8.59% |
| Q2 2023 | 6.05% |
| Q1 2023 | -30.26% |
| Q4 2022 | 37.09% |
| Q3 2022 | 5.02% |
| Q2 2022 | 11.16% |
| Q1 2022 | -19.08% |
| Q4 2021 | -2.21% |
| Q3 2021 | 23.37% |
| Q2 2021 | 1.97% |
| Q1 2021 | -17.94% |
| Q4 2020 | 20.78% |
| Q3 2020 | -13.58% |
| Q2 2020 | 18.13% |
| Q1 2020 | -8.08% |
| Q4 2019 | 0.50% |
| Q3 2019 | 11.69% |
| Q2 2019 | 7.87% |
| Q1 2019 | -7.90% |
| Q4 2018 | 8.91% |
| Q3 2018 | 6.81% |
| Q2 2018 | 2.32% |
| Q1 2018 | -25.23% |
| Q4 2017 | 15.47% |
| Q3 2017 | -16.90% |
| Q2 2017 | 31.25% |
| Q1 2017 | -3.32% |
| Q4 2016 | 9.00% |
| Q3 2016 | 2.59% |
| Q2 2016 | 8.96% |
| Q1 2016 | -22.68% |
| Q4 2015 | 27.45% |